Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 3176 of 5804
-
Brain training shows promise for TBI recovery
Symptom relief OngoingThe purpose of this investigation is to conduct a series of case studies on the impact of LearningRx cognitive training on cognitive skills, daily functioning, and workplace self-efficacy for participants with Traumatic Brain Injury (TBI) /Acquired Brain Injury (ABI).
Phase: NA • Sponsor: Gibson Institute of Cognitive Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Tablet screening could help HIV patients get help for addiction and depression
Knowledge-focused CompletedSubstance use disorders (SUDs), depression and anxiety in HIV-infected patients result in poor HIV outcomes, yet are often unrecognized and untreated. To address these problems, this study examines the implementation and effectiveness of a clinical intervention consisting of self…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Which obesity surgery is safer? new trial pits standard vs. simpler approach
Disease control OngoingThe aim of the Torsby I Trial is to identify differences and similarities between a standard duodenal switch (DS) and a single-anastomosis duodeno-ileostomy (SADI) regarding effect on weight, comorbidities and malnutrition.
Phase: NA • Sponsor: Värmland County Council, Sweden • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Natural supplement shows promise for shedding body fat
Disease control CompletedThe purpose of this clinical study is to determine the effect and safety of long-term intake of enzymatically modified isoquercitrin (EMIQ), a natural plant product on body fat loss in obese and overweight individuals.
Phase: NA • Sponsor: Tufts University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Heart stent showdown: ultimaster vs. the rest in 1,000 patients
Disease control CompletedThe purpose of this study is to evaluate the relative effectiveness and safety of Ultimaster stent compared to other drug eluting stents.
Sponsor: Duk-Woo Park, MD • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Massive study aims to unlock genetic secrets of childhood hormone disorders
Knowledge-focused Recruiting nowBackground: Endocrine glands give off hormones. Researchers want to learn more about the disorders that affect these glands in children. These disorders might be caused by changes in genes. Genes contain DNA, which is the blueprint of how a cell works. Researchers want to identi…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Brain zaps show promise for silencing hallucinations
Symptom relief CompletedThe present study aims to investigate whether transcranial direct current stimulation (tDCS) reduces auditory hallucinations in patients with psychosis. In addition, the neuronal changes of tDCS will be examined.
Phase: NA • Sponsor: University of Bergen • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New brain scan tracks Dementia-Linked tau buildup in rare language disorders
Knowledge-focused CompletedThis study is designed to learn more about overall tau burden in the brain of patients with Primary Progressive Aphasia (PPA) and Frontotemporal Dementia.
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Can a white blood cell booster heal a rare skin emergency?
Disease control CompletedNeupoNET aims to evaluate interest of G-CSF in the treatment of Toxic Epidermal necrolysis. This is a prospective randomized controlled trial. Patients will be allocated in a treatment group (receiving an injection of 5 microg/kg/d of G-CSF during 5 consecutive days) or in a pla…
Phase: PHASE4 • Sponsor: University of Liege • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Pacemaker algorithm could spot sleep apnea without extra tests
Diagnosis CompletedLittle is known about potential relationships between sleep apnea, plasma aldosterone and diastolic dysfunction which is a very frequent finding among patients requiring permanent cardiac pacing. Sleep apnea is often under diagnosed by clinical examination. Confirmation tests are…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Shocking vs pedaling: which builds stronger lungs?
Symptom relief CompletedThe aim of this study is to evaluate the effectiveness of quadriceps strengthening with neuromuscular electrical stimulation versus cycle ergometer as part of pulmonary rehabilitation program , in patients with severe or very severe COPD , according to GOLD with BODE index ≥ 5 .…
Phase: NA • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New needle treatment may replace surgery for stubborn tennis elbow
Symptom relief CompletedLateral epicondylosis, also called tennis elbow or lateral epicondylitis, is a prevalent, painful syndrome of the elbow. It is refractory to conservative treatment measures, including rest, excentric and concentric exercises in approximately 20% of patients after 6 months. Cortic…
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Symptom relief
Last updated Jun 26, 2026 17:00 UTC
-
Brain scans aim to unlock dementia secrets in Parkinson's
Knowledge-focused Recruiting nowThe purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine dementia subtypes in patients with Parkinson disease (PD). The ultimate goal of this project is to be…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Hepatitis b drug trial halted early after safety check
Disease control TerminatedNormal healthy volunteer (NHV) participants will enroll sequentially into a total of 6 escalating dose levels (6 subjects per dose level), randomized to receive a single dose of ARC-521 Injection or placebo. The maximum study duration for NHVs is approximately 21 weeks. Hepatiti…
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New seed method may sharpen breast cancer surgery
Symptom relief CompletedThis is a monocentric, non-inferiority, randomized cohort study with an open 1:1 ratio comparing the impact of iodine seed tumor localization (arm B) vs. standard localization using a metal guide (arm A) on the quality of the surgical resection margins in parallel groups with an …
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New camera tech could catch mouth cancer earlier
Diagnosis OngoingThis early phase I trial studies how well multimodal imaging works for surveillance in patients with oral potentially malignant disorders. New types of imaging devices may help doctors decide if a lesion in the mouth is pre-cancerous or cancerous.
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
New cancer drug trial halted early – what we know
Disease control TerminatedThe purpose of the Study is to select a dose and assess the safety and tolerability of INCB057643 as a monotherapy (Part 1 and Part 2) and in combination with standard-of-care (SOC) agents (Part 3 and Part 4) for subjects with advanced malignancies. Part 1 will determine the max…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Gene test could help smokers quit by matching them to the right drug
Knowledge-focused CompletedNicotine mediates smoking's addictive effects in the brain. The ratio of 3-hydroxycotinine to cotinine, known as the nicotine metabolite ratio, or NMR, is a genetically- informed biomarker reflecting hepatic CYP2A6 activity and the rate of nicotine metabolism. In light of a recen…
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Simple walk test could forecast lung transplant need in cystic fibrosis
Knowledge-focused CompletedThe purpose of this study is to determine whether the 6-minute walk test (6MWT) could be a prognostic factor for cystic fibrosis patients.
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Cancer drug trial halted early: what we know
Disease control TerminatedThis is an open-label, dose-escalation/dose-expansion study of INCB059872 in subjects with advanced malignancies. The study will be conducted in 4 parts. Part 1 (mono therapy dose escalation) will determine the recommended dose(s) of INCB059872 for dose expansion, based on maximu…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC